Research exploring the first visible changes in the brain is helping scientists evaluate new potential treatments for Alzheimer’s.
The modernization and miniaturization of pharmaceutical production could expand the range of ingredients medicinal chemists use to make new drugs.
Researchers discover that networks of proteins circulating in the blood influence the development and progression of chronic diseases.
Novartis-Harvard team identifies a new type of cell that is key to the disease.
Follow Dr. Cobos as he works to provide a patient with a new liver and performs surgery using a tiny video camera.
Novartis researchers are searching for more effective ways to discover drugs for neurological and psychiatric diseases.
Review the strategy and annual performance of Novartis and read letters from our Chairman and CEO.
This site is intended for a global audience.